Visit Your Local PBS Station PBS Home PBS Home Programs A-Z TV Schedules Watch Video Support PBS Shop PBS Search PBS

   
the Online NewsHour
E-mail This Page Print This Page
the Online NewsHourChevronIntelBNSF RailwayWells FargoToyotaMonsantoCorporation for Public Broadcasting
BROWSE BY
REGION
TOPIC
RECENT PROGRAMSLOCAL TV LISTINGSSUBSCRIPTIONSTEACHER RESOURCESSEARCH


REGION: North America
TOPIC: Health
Online NewsHour
UPDATE Posted: October 5, 2009, 6:10 PM ET    

Nobel Prize for Medicine Goes to American Trio

Three Americans were named the 2009 winners of the Nobel Prize in Medicine Monday for their work identifying a key growth enzyme that has important implications for research on aging, and for diseases like cancer.
Carol Greider, Courtesy Nobelprize.org

When a cell divides, the end, called a tenomere, becomes shorter, but the three discovered an enzyme, called telomerese, that can lengthens the tenomere, and therefore keeping the cell protected.

"It gives us a way to understand the balance that occurs in cells," explained one of the winners, Carol Greider, a professor of microbiology and genetics at Johns Hopkins Institute for Basic Biomedical Sciences. The trio made the Nobel-worthy discovery in the late 70's and early 80's.

The other winners are Elizabeth Blackburn, an Australian-born molecular biologist and biochemist at the University of California San Francisco, and Jack Szostak, a British-born professor of genetics at Harvard Medical School and a researcher with the Howard Hughes Medical Institute. This is the first year two women have shared the prize for Medicine.

"We have fifty percent of the brains out there," Greider told the NewsHour, "but it's true that there haven't been as many women lab heads in the past. And so what I'm hoping is that as the Nobels start to catch up, it will be more reflective of the kind of discoveries being made by women."

The discovery has implications on issues like aging and cancer. "If you can block the telomerase from acting, then the tenomeres will naturally become shorter and then you'd have a way to actually kill those cancer cells," explained Greider. She says, though, that researchers still need to answer the question "whether or not that would actually be a useful treatment now in human patients."

Greider spoke with the NewsHour earlier today by phone from Baltimore. Listen to the full interview here:


---- Interview by Mike Melia, NewsHour With Jim Lehrer

ONLINE NEWSHOUR LINKS

October 5, 2009
Official Nobel Prize Web Site

October 6, 2008
In 2008, European Scientists Shared Nobel Prize for Medicine




CURRENT NEWSHOUR HEADLINES
Bound for Copenhagen, Obama Faces Climate Change Obstacles

How Would Obama's Troops Decision Impact Afghan War?

Dollar's Weakness Inspires Modern-day Gold Rush







LATEST HEALTH HEADLINES
Dr. Kessler Delves Into the Mysteries of Food Cravings
How Will Proposed Health Care Overhaul Affect Patients?
Other News: Recession Complicates Holiday Travel for Many
ABOUT US | FEEDBACK | SUBSCRIPTIONS / FEEDS: 
POD|RSS
Funded, in part, by:ChevronIntelBNSF RailwayWells FargoToyotaMonsantoCorporation for Public Broadcasting
            Support the kind of journalism done by the NewsHour...Become a member of your local PBS station.
PBS Online Privacy Policy

Copyright ©1996- MacNeil/Lehrer Productions. All Rights Reserved.